Cardiol Historical Balance Sheet

CRDL Stock

CAD 1.45 0.03 2.11%

Trend analysis of Cardiol Therapeutics Class balance sheet accounts such as Short Long Term Debt Total of 133.9 K, Other Current Liabilities of 5.1 M or Total Current Liabilities of 5.5 M provides information on Cardiol Therapeutics' total assets, liabilities, and equity, which is the actual value of Cardiol Therapeutics to its prevalent stockholders. By breaking down trends over time using Cardiol Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Cardiol Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cardiol Therapeutics is a good buy for the upcoming year.

Cardiol Therapeutics Inventory

289,889

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardiol Therapeutics Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Cardiol Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Cardiol Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Cardiol Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cardiol Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cardiol currently owns. An asset can also be divided into two categories, current and non-current.

Cardiol Therapeutics Balance Sheet Chart

At this time, Cardiol Therapeutics' Cash And Equivalents is very stable compared to the past year. As of the 27th of March 2025, Short Term Debt is likely to grow to about 33.5 K, while Total Assets are likely to drop about 38.6 M.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Cardiol Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cardiol Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Cardiol Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Cardiol Therapeutics Class are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Cardiol Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Cardiol Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardiol Therapeutics Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	72.9K	174.3K	156.9K	133.9K
Total Assets	62.0M	36.7M	42.2M	38.6M

Short Long Term Debt Total Total Assets

Cardiol Therapeutics balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Cash And Equivalents
Total Assets		-0.67	0.93	0.95	1.0	0.96	0.57	-0.99	-0.78	0.74	1.0	-0.34	-0.75	1.0	0.49	0.8	0.7	-0.72	-0.72	0.5	0.75	0.95	0.96	0.8	1.0	0.92
Short Long Term Debt Total	-0.67		-0.75	-0.69	-0.66	-0.6	-0.5	0.71	0.64	-0.59	-0.71	0.21	0.65	-0.71	-0.2	-0.48	-0.66	0.81	0.96	-0.31	-0.62	-0.69	-0.6	-0.67	-0.67	-0.67
Other Current Liab	0.93	-0.75		0.99	0.91	0.97	0.61	-0.93	-0.9	0.84	0.95	-0.48	-0.8	0.95	0.35	0.81	0.9	-0.87	-0.75	0.38	0.85	0.99	0.97	0.9	0.93	0.95
Total Current Liabilities	0.95	-0.69	0.99		0.93	0.99	0.59	-0.94	-0.9	0.85	0.96	-0.51	-0.79	0.96	0.38	0.84	0.88	-0.84	-0.71	0.37	0.86	1.0	0.99	0.88	0.95	0.96
Total Stockholder Equity	1.0	-0.66	0.91	0.93		0.94	0.57	-0.99	-0.74	0.71	0.99	-0.31	-0.74	0.99	0.51	0.78	0.66	-0.68	-0.72	0.51	0.72	0.93	0.94	0.77	1.0	0.9
Net Tangible Assets	0.96	-0.6	0.97	0.99	0.94		0.61	-0.94	-0.87	0.82	0.96	-0.45	-0.79	0.96	0.46	0.85	0.84	-0.79	-0.64	0.45	0.84	0.99	1.0	0.88	0.96	0.95
Property Plant And Equipment Net	0.57	-0.5	0.61	0.59	0.57	0.61		-0.52	-0.7	0.5	0.54	0.26	-0.95	0.54	0.75	0.85	0.58	-0.73	-0.68	0.8	0.73	0.58	0.61	0.87	0.57	0.59
Net Debt	-0.99	0.71	-0.93	-0.94	-0.99	-0.94	-0.52		0.75	-0.71	-1.0	0.35	0.72	-1.0	-0.42	-0.75	-0.68	0.71	0.74	-0.44	-0.71	-0.94	-0.94	-0.76	-0.99	-0.91
Retained Earnings	-0.78	0.64	-0.9	-0.9	-0.74	-0.87	-0.7	0.75		-0.95	-0.78	0.49	0.87	-0.78	-0.44	-0.85	-0.92	0.94	0.66	-0.39	-0.98	-0.9	-0.87	-0.91	-0.78	-0.92
Accounts Payable	0.74	-0.59	0.84	0.85	0.71	0.82	0.5	-0.71	-0.95		0.74	-0.66	-0.72	0.74	0.39	0.73	0.89	-0.86	-0.57	0.29	0.94	0.86	0.82	0.79	0.74	0.91
Cash	1.0	-0.71	0.95	0.96	0.99	0.96	0.54	-1.0	-0.78	0.74		-0.39	-0.73	1.0	0.42	0.77	0.72	-0.73	-0.74	0.43	0.75	0.96	0.96	0.79	1.0	0.93
Non Current Assets Total	-0.34	0.21	-0.48	-0.51	-0.31	-0.45	0.26	0.35	0.49	-0.66	-0.39		0.02	-0.39	0.33	-0.16	-0.57	0.36	0.02	0.46	-0.45	-0.51	-0.46	-0.2	-0.35	-0.53
Non Currrent Assets Other	-0.75	0.65	-0.8	-0.79	-0.74	-0.79	-0.95	0.72	0.87	-0.72	-0.73	0.02		-0.73	-0.68	-0.93	-0.75	0.88	0.78	-0.7	-0.89	-0.79	-0.79	-0.95	-0.75	-0.8
Cash And Short Term Investments	1.0	-0.71	0.95	0.96	0.99	0.96	0.54	-1.0	-0.78	0.74	1.0	-0.39	-0.73		0.42	0.77	0.72	-0.73	-0.74	0.43	0.75	0.96	0.96	0.79	1.0	0.93
Net Receivables	0.49	-0.2	0.35	0.38	0.51	0.46	0.75	-0.42	-0.44	0.39	0.42	0.33	-0.68	0.42		0.65	0.28	-0.37	-0.4	0.92	0.48	0.38	0.46	0.6	0.49	0.41
Common Stock Total Equity	0.8	-0.48	0.81	0.84	0.78	0.85	0.85	-0.75	-0.85	0.73	0.77	-0.16	-0.93	0.77	0.65		0.75	-0.76	-0.62	0.57	0.85	0.84	0.85	0.92	0.79	0.8
Common Stock Shares Outstanding	0.7	-0.66	0.9	0.88	0.66	0.84	0.58	-0.68	-0.92	0.89	0.72	-0.57	-0.75	0.72	0.28	0.75		-0.91	-0.64	0.26	0.88	0.88	0.84	0.89	0.7	0.83
Long Term Debt Total	-0.72	0.81	-0.87	-0.84	-0.68	-0.79	-0.73	0.71	0.94	-0.86	-0.73	0.36	0.88	-0.73	-0.37	-0.76	-0.91		0.81	-0.42	-0.93	-0.84	-0.79	-0.91	-0.72	-0.86
Non Current Liabilities Total	-0.72	0.96	-0.75	-0.71	-0.72	-0.64	-0.68	0.74	0.66	-0.57	-0.74	0.02	0.78	-0.74	-0.4	-0.62	-0.64	0.81		-0.5	-0.65	-0.7	-0.64	-0.76	-0.72	-0.67
Other Current Assets	0.5	-0.31	0.38	0.37	0.51	0.45	0.8	-0.44	-0.39	0.29	0.43	0.46	-0.7	0.43	0.92	0.57	0.26	-0.42	-0.5		0.44	0.37	0.45	0.61	0.49	0.4
Other Stockholder Equity	0.75	-0.62	0.85	0.86	0.72	0.84	0.73	-0.71	-0.98	0.94	0.75	-0.45	-0.89	0.75	0.48	0.85	0.88	-0.93	-0.65	0.44		0.86	0.84	0.9	0.75	0.92
Total Liab	0.95	-0.69	0.99	1.0	0.93	0.99	0.58	-0.94	-0.9	0.86	0.96	-0.51	-0.79	0.96	0.38	0.84	0.88	-0.84	-0.7	0.37	0.86		0.99	0.88	0.95	0.96
Net Invested Capital	0.96	-0.6	0.97	0.99	0.94	1.0	0.61	-0.94	-0.87	0.82	0.96	-0.46	-0.79	0.96	0.46	0.85	0.84	-0.79	-0.64	0.45	0.84	0.99		0.88	0.96	0.95
Property Plant And Equipment Gross	0.8	-0.67	0.9	0.88	0.77	0.88	0.87	-0.76	-0.91	0.79	0.79	-0.2	-0.95	0.79	0.6	0.92	0.89	-0.91	-0.76	0.61	0.9	0.88	0.88		0.8	0.84
Total Current Assets	1.0	-0.67	0.93	0.95	1.0	0.96	0.57	-0.99	-0.78	0.74	1.0	-0.35	-0.75	1.0	0.49	0.79	0.7	-0.72	-0.72	0.49	0.75	0.95	0.96	0.8		0.92
Cash And Equivalents	0.92	-0.67	0.95	0.96	0.9	0.95	0.59	-0.91	-0.92	0.91	0.93	-0.53	-0.8	0.93	0.41	0.8	0.83	-0.86	-0.67	0.4	0.92	0.96	0.95	0.84	0.92

Click cells to compare fundamentals

Cardiol Therapeutics Account Relationship Matchups

Cardiol Therapeutics balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	15.9M	87.9M	62.0M	36.7M	42.2M	38.6M
Short Long Term Debt Total	156.6K	117.6K	72.9K	174.3K	156.9K	133.9K
Other Current Liab	2.5M	11.5M	9.8M	8.3M	9.5M	5.1M
Total Current Liabilities	2.5M	11.6M	9.8M	8.3M	9.5M	5.5M
Total Stockholder Equity	13.3M	76.2M	52.2M	28.2M	32.5M	33.0M
Net Tangible Assets	14.1M	12.8M	75.9M	51.9M	59.7M	32.7M
Property Plant And Equipment Net	479.6K	356.5K	295.7K	337.1K	387.6K	329.6K
Net Debt	(13.9M)	(83.8M)	(59.4M)	(34.7M)	(31.2M)	(32.8M)
Retained Earnings	(51.9M)	(83.5M)	(114.4M)	(142.6M)	(128.3M)	(121.9M)
Accounts Payable	1.8K	4.2M	8.3M	7.6M	8.8M	9.2M
Cash	14.0M	83.9M	59.5M	34.9M	40.1M	34.3M
Non Current Assets Total	943.2K	735.7K	590.5K	547.4K	492.7K	610.6K
Cash And Short Term Investments	14.0M	83.9M	59.5M	34.9M	40.2M	34.3M
Net Receivables	219.9K	407.1K	480.2K	279.9K	321.9K	452.2K
Common Stock Shares Outstanding	29.9M	43.2M	62.5M	64.5M	74.1M	41.5M
Long Term Debt Total	140.3K	104.7K	72.9K	22.4K	20.2K	19.2K
Liabilities And Stockholders Equity	15.9M	87.9M	62.0M	36.7M	42.2M	38.6M
Non Current Liabilities Total	104.7K	72.9K	22.4K	158.5K	142.7K	109.5K
Other Current Assets	686.9K	2.8M	1.5M	941.4K	1.1M	1.9M
Other Stockholder Equity	8.8M	12.7M	15.6M	18.8M	21.6M	22.7M
Total Liab	2.6M	11.6M	9.8M	8.5M	9.7M	5.7M
Net Invested Capital	14.7M	13.3M	76.2M	52.2M	60.0M	33.4M
Property Plant And Equipment Gross	584.0K	479.6K	713.9K	788.6K	906.9K	478.6K
Total Current Assets	14.9M	87.1M	61.4M	36.2M	41.6M	37.8M
Accumulated Other Comprehensive Income	(76.3K)	4.5M	4.2M	3.5M	4.0M	2.4M
Cash And Equivalents	7.0M	14.0M	83.9M	59.5M	68.4M	71.8M
Net Working Capital	13.7M	12.4M	75.6M	51.6M	59.4M	32.5M
Short Term Debt	51.9K	44.7K	50.4K	15.8K	18.2K	33.5K
Intangible Assets	463.7K	379.2K	294.8K	210.4K	189.3K	371.0K
Common Stock	51.9M	142.9M	147.5M	148.5M	170.8M	89.8M
Property Plant Equipment	584.0K	479.6K	356.5K	295.7K	340.1K	322.7K
Capital Surpluse	4.8M	8.8M	12.7M	15.6M	17.9M	9.5M
Capital Stock	39.4M	51.9M	142.9M	147.5M	169.7M	92.1M
Current Deferred Revenue	(1.8K)	(4.2M)	(8.3M)	(7.6M)	(6.9M)	(6.5M)

Pair Trading with Cardiol Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cardiol Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiol Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Cardiol Stock

0.62	BOFA	Bank of America	Pair Corr
0.69	RY	Royal Bank	Pair Corr

Moving against Cardiol Stock

0.51	TD	Toronto Dominion Bank	Pair Corr
0.35	RY-PO	Royal Bank	Pair Corr

The ability to find closely correlated positions to Cardiol Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardiol Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardiol Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardiol Therapeutics Class to buy it.

The correlation of Cardiol Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardiol Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardiol Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Cardiol Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Cardiol Therapeutics is a strong investment it is important to analyze Cardiol Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cardiol Therapeutics' future performance. For an informed investment choice regarding Cardiol Stock, refer to the following important reports:

How To Invest In Cardiol

Details

Is Cardiol Stock a good investment?

Details

What is Cardiol Therapeutics' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Please note, there is a significant difference between Cardiol Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardiol Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardiol Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cardiol Historical Balance Sheet

Cardiol Therapeutics Inventory

289,889

About Cardiol Balance Sheet Analysis

Cardiol Therapeutics Balance Sheet Chart

Total Assets

Total Current Liabilities

Cardiol Therapeutics balance sheet Correlations

Cardiol Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cardiol Therapeutics balance sheet Accounts

Pair Trading with Cardiol Therapeutics

Moving together with Cardiol Stock

Moving against Cardiol Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Total Current Assets	+ 1.0	Total Stockholder Equity

Cash And Short Term Investments	- 1.0	Net Debt
Cash	- 1.0	Net Debt
Total Current Assets	- 0.99	Net Debt
Net Debt	- 0.99	Total Stockholder Equity
Net Debt	- 0.99	Total Assets
Other Stockholder Equity	- 0.98	Retained Earnings